With regard to the essential role of hepatic acetyl-CoA in the mediation of WAT-derived FFA in hepatic insulin insensitivity (2), we hypothesized that Phillyrin treatment could reduce the FFA flux from dysfunctional WAT to liver in obesity. The gene discussed is INS; the disease is obesity disorder.